Lunai Bioworks (LNAI) Stock Jumps 81% After Nasdaq Compliance News

TLDR

• LNAI surged 80.88% to $5.15 in after-hours trading on Tuesday
• Nasdaq confirmed on June 11 that Lunai Bioworks regained compliance with the $1.00 minimum bid price rule
• The company now enters a mandatory one-year monitoring period on Nasdaq
• If LNAI falls below $1.00 again during that period, Nasdaq can issue a delisting notice with no grace period
• The stock has dropped 90.11% over the past 12 months and remains near its 52-week low

Lunai Bioworks (LNAI) stock rocketed 80.88% to $5.15 in after-hours trading on Tuesday. The move came after the company filed with the SEC disclosing that Nasdaq had confirmed it regained compliance with the exchange’s $1.00 minimum bid price requirement.

Lunai Bioworks Inc., LNAI

During the regular session on Tuesday, LNAI had already closed up 9% at $2.84 before the after-hours surge.

The news follows a Nasdaq Hearings Panel notification sent to the company on June 11. The panel confirmed Lunai had satisfied both the Bid Price Rule and the conditions set out in panel extension letters issued on April 20 and May 12.

This was not a straightforward path back. Lunai had to meet the terms of two separate extension letters to earn its way back into compliance.

One-Year Monitoring Period Begins

With compliance restored, Lunai now enters a mandatory one-year monitoring period. During this window, Nasdaq will keep a close watch on the stock.

If LNAI drops below the $1.00 minimum bid price at any point during that year, Nasdaq will issue a delisting determination letter — and there will be no grace period or compliance plan allowed this time around.

Lunai does retain one option: it can request a new hearing before the Nasdaq Hearings Panel. Filing that request would pause any suspension or delisting action until the panel issues a final decision.

Trading volume told its own story on Tuesday. Volume surged to 19.33 million — roughly 33.4 times the stock’s average daily volume of 578,990.

The RSI stood at 50.69, sitting near neutral territory.

Stock Still Deep in the Red Over 12 Months

Despite Tuesday’s pop, the broader picture for LNAI is still rough. Over the past 12 months, the stock has fallen 90.11%.

The 52-week high sits at $31.75. The 52-week low is $1.21. LNAI is currently trading close to that annual low.

Lunai’s market cap stood at approximately $12.90 million at the time of the after-hours move.

Short interest is at 8.72%, and the technical sentiment signal is listed as “Sell.”

The company’s restored Nasdaq listing gives it continued access to the exchange, but the one-year monitoring period keeps the pressure on management to hold the stock above $1.00.

The SEC filing disclosing the compliance news was the catalyst for Tuesday’s after-hours move.

The post Lunai Bioworks (LNAI) Stock Jumps 81% After Nasdaq Compliance News appeared first on CoinCentral.